Do all estrogens pose the same threat of venous thrombosis?

Experts urge the FDA to update outdated warnings on menopausal hormone therapies, emphasizing the safety and benefits of low-dose vaginal estrogen.

In this episode of Pap Talk, Jean Dubuisson, MD, PhD, discusses the first successful hysterectomy performed using the MIRA surgical system.

Infants born preterm or with complications face higher risks of chronic conditions in adulthood, highlighting policy and health care needs.

DiaMedica Therapeutics' investigational therapy DM199 significantly reduced blood pressure and improved uterine blood flow in patients with preeclampsia, with a favorable safety profile.

Tirzepatide and menopause hormone therapy may significantly enhance weight loss and health outcomes in postmenopausal women.